News and Trends 18 Nov 2022
Novavax’ COVID-19 vaccine gets expanded authorization for booster in adults
Novavax, Inc., a U.S-based biotechnology company announced today (November 18) that Health Canada has granted expanded authorization for Covid-19 vaccine Nuvaxovid. The vaccine NVX-CoV2373 for active immunization to prevent the…